When: Weekly close <$186 with 200 SMA slope flattening

Then: Full exit, structural thesis broken

SUPPORT 35% TRIM WITH REDEPLOYMENT; OPPOSE ADDING ON WEAKNESS BELOW 210

• Anthropic catalyst is one rumor echoing through press cycle, not four independent confirmations; optionality collapses to zero if deal slips to 2027 due to Iran situation
• MACD at plus 0.22 with histogram of plus 0.23 is smallest possible bullish crossover, not powerful setup; VWMA declined from roughly 219 in early July to 214 today while price held above it indicates distribution in slow motion
• 422 billion in total debt against 106 billion in common equity with beta of 1.21 creates amplified drawdown risk in correlated risk-off events (geopolitical shock plus credit spread widening)
• 21 percent of net income exposed to 100 basis point credit spread widening; first half record profitability reflected cooperative environment not guaranteed into Q4
• 2.6 billion in AUA attrition represents single basis points but issue is trend; UBS had 2.65 billion recruiting day, Merrill building US wealth franchise, competitive intensity increasing
• PEG ratio of 1.91 at 52-week highs with unconfirmed catalyst and rising geopolitical tail risk does not justify concentration increase
• Stop loss at 225 is only 8.50 above entry of 216.50 (roughly 3.9 percent) versus ATR of 4.84, too tight and prone to whipsaw on deal-delay headlines
• 65 percent rally from August 2025 lows should be partially locked in while optionality still priced in rather than waiting for confirmation or timing slip

→ vs aggressive: Anthropic probability haircut to 50 percent still called asymmetric upside; bear case is near-zero optionality, not coin flip with positive value on both sides; requires timing, mandate, valuation, and macro conditions to align simultaneously

→ vs aggressive: Coiled spring interpretation unsupported by data; MACD spent most of August in negative territory at minus 1.30 and minus 1.27 showing real buyers stepped away; VWMA declining while price holds above is distribution, not accumulation

→ vs aggressive: Record profitability does not eliminate credit spread exposure; leverage amplifies drawdowns in correlated risk-off events (geopolitical escalation plus credit stress plus advisor attrition accelerating simultaneously)

→ vs aggressive: 93 percent odds of no Fed cuts and 8 percent recession probability reflect current state, not next 8 weeks; Iran situation flagged as biggest threat to IPO timing is live risk that could eliminate Anthropic catalyst while also causing selloff MS falls harder into due to 1.21 beta

→ vs aggressive: Adding on flush below 210 is treating reported news as confirmed and letting position sizing drift against prudent limits; 52-week highs with PEG of 1.91 and unconfirmed catalyst is precisely wrong moment for concentration build

→ vs aggressive: Stop loss placement of 225 (3.9 percent from entry) will get whipsawed given ATR of 4.84; needs wider stop to survive deal-delay headline that could drop stock 5 to 7 percent on no fundamental change

Trim 20-25% at current levels; retain stub to participate in Anthropic catalyst if confirmed within 1-2 weeks; hard stop on stub at $207; scale out further at $220-$225 on confirmed rally; redeploy half proceeds into defensive sleeve (JPM preferred) with other half in cash/Treasuries; add back to 30-35% of trim on confirmed lead-left announcement; do not add on weakness below $210 into catalyst uncertainty.

• Anthropic catalyst probability assessed at 50-70%: multi-quarter earnings driver with league-table credit if MS gets lead-left on prospectus filing in 1-2 week window
• Recommended trim of 20-25% (not 35%): sufficient to lock in gains and address concentration, preserves stub participation; anything heavier overpays for downside protection given defined catalyst timeline
• Dry powder strategy: half proceeds in cash or short-duration Treasuries, half in JPM preferred or defensive sleeve; full redeployment into substitute positions sacrifices optionality if catalyst confirms within 2 weeks
• Hard stop on stub repositioned to $207 (below August 20 intraday low and lower Bollinger band at $209.55); ATR is 4.84; current $225 stop is mechanically flawed and functions as tactical scale-out, not risk management stop
• Technical picture shows equilibrium: price at $214-$215 clustered with 50 SMA, 10 EMA, Bollinger midline, and VWMA; MACD at 0.22 with histogram at 0.23 is marginal bullish; RSI at 52.49 is neutral; next move catalyst-driven, not technically driven
• Advisor attrition impact is sub-50 basis points revenue impact; $2.6B AUA loss out of over $6T is noise; structural overhang already priced into multiple
• Adding on weakness below $210 into catalyst window is wrong positioning: if Anthropic confirms, stock breaks out and position is missed; if deal slips or goes elsewhere, $210 may not hold as support
• Structural risk: $422B debt pile on $106B common equity base with beta at 1.21 amplifies drawdowns in correlated risk-off scenarios (Iran escalation plus credit stress plus wealth client volatility); asymmetric downside exists despite Anthropic upside optionality
• Stock corrected 11% in two weeks; six-week consolidation in tight range; VWMA trending lower while price holds is ambiguous (thinning bid vs. volume-weighted mean reversion)

→ vs aggressive: Overreaches by using concession on OCF critique to dismiss entire leverage conversation; $422B debt on $106B equity with 1.21 beta amplifies correlated drawdowns; base case assumes cooperative first-half 2026 environment persists but rising tail risk is flagged by own macro report

→ vs conservative: 35% trim at $216 before confirmed lead-left mandate pays permanent opportunity cost at worst moment in catalyst cycle; overpaying for downside protection when catalyst has defined 1-2 week resolution path

→ vs aggressive: Adding on flush below $210 treats this as value entry when it is actually catalyst-dependent trade; pre-resolution adds are how good theses become blown-up position sizing

→ vs neutral: Both aggressive and conservative analysts overinterpret same technical data; MACD, RSI, VWMA patterns are ambiguous at equilibrium; Anthropic prospectus filing and Iran situation are actual decision variables, not MACD patterns